Geron Corporation
(NASDAQ : GERN)

( )
GERN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading GERN News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.84%166.041.2%$746.09m
INCYIncyte Corporation
-1.64%138.971.7%$615.47m
GILDGilead Sciences, Inc.
-0.50%67.491.0%$591.26m
CELGCelgene Corporation
-0.12%123.221.0%$511.52m
BIIBBiogen Inc.
-0.89%275.411.3%$448.41m
REGNRegeneron Pharmaceuticals, Inc.
-1.12%365.022.1%$314.21m
ALXNAlexion Pharmaceuticals, Inc.
0.15%120.261.6%$206.10m
KITEKite Pharma, Inc.
-2.46%74.5018.8%$204.96m
TSROTESARO, Inc.
-1.39%153.6216.1%$174.99m
ESPREsperion Therapeutics, Inc.
3.56%40.4018.7%$170.36m
ILMNIllumina, Inc.
-0.06%167.693.7%$165.15m
AUPHAurinia Pharmaceuticals Inc.
-1.64%8.396.3%$146.33m
CLVSClovis Oncology, Inc.
2.01%68.5317.5%$144.30m
VRTXVertex Pharmaceuticals Incorporated
-1.10%89.052.2%$133.48m
GBTGlobal Blood Therapeutics Inc
1.45%38.5511.9%$106.01m

Company Profile

Geron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.